Pune (Maharashtra) [India], June 29 (ANI): India's first indigenously developed mRNA vaccine against the COVID-19 gets the Emergency Use Authorization (EUA), to be sold under the brand name GEMCOVAC™-19 and will be rolled out soon, informed the officials on Wednesday.
The Italian No.8 seed, who had won back-to-back grass titles during his Wimbledon preparations, said he was "heartbroken" to have to miss out. "The dream is over for this year but I will come back stronger."
Islamabad [Pakistan], June 29 (ANI): Pakistan on Wednesday reported 541 new COVID-19 infections overnight, the first time in three months, raising the positivity ratio above 3 per cent again.
Seoul [South Korea], June 29 (ANI/Xinhua): South Korea recorded 10,463 new COVID-19 cases as of midnight Tuesday compared to 24 hours ago, bringing the total tally to 18,349,756, the health authorities said Wednesday.
Kurla (Mumbai) [India], June 29 (ANI): The Mumbai Police on Wednesday said that a total of 19 people were killed and 15 people sustained injuries after a building collapse in Kurla area of Mumbai on Monday.
Mexico City [Mexico], June 29 (ANI/Xinhua): Mexico has seen 10 weeks of increase in COVID-19 cases though the hospitalization rate remains low, the Undersecretary of Prevention and Health Promotion Hugo Lopez-Gatell said Tuesday.
Belgrade [Serbia], June 29 (ANI/Xinhua): A total of 810 new COVID-19 cases were registered in Serbia, the highest in two months, said the Institute of Public Health of Serbia on Tuesday.
New Delhi [India], June 29 (ANI): India's educational and household conditions have improved due to the targeted efforts of the government through several social protection schemes, especially in the areas of water availability and sanitation, the State of Inequality in India Report revealed
Dhaka [Bangladesh], June 29 (ANI): Amid a fresh surge in Covid-19 cases in Bangladesh, the Cabinet Division issued a circular with six points directive.
New Delhi [India], June 28 (ANI): The Drugs Controller General of India (DCGI) has given restricted emergency use authorisation (EUA) to Pune-based Serum Institute of India's COVID-19 vaccine 'Covovax' for children aged 7 to 12 years, sources told ANI.